Peter Connolly

Peter is a Managing Director, member of the Executive Committee and head of North America for Cobepa S.A., a private equity investor with offices in New York and Brussels.  Cobepa is currently managing a $3.0 billion evergreen private equity fund and is backed by a group of European family offices.  Peter joined Cobepa in 2015 and serves on three Cobepa boards: BioAgilytix (large molecule pharmaceutical services); Project X (an undisclosed technology-enabled B2B business); and Le Pain Quotidien (a global restaurant chain).  Prior to joining Cobepa, Peter worked at Summit Partners (2004-2015) leading growth equity and growth buyout investments, including serving as co-lead the healthcare team and also focusing on B2B services/tech investments.

He is currently a board member of CareCentirx and Solutionreach and is a past board member of MedSpring Urgent Care, ABILITY Networks, Associa, Bartlett Holdings and Aurora Diagnostics. Prior to his time at Summit Partners, Peter worked in the Investment Banking Division of Goldman, Sachs & Co. and with Deloitte.

Peter graduated from the University of Notre Dame (magna cum laude) and the Stern School of Business at NYU (With Distinction).